CSI Reaffirms Commitment to the United Nations Global Compact

Clinical Services International (CSI) is proud to reaffirm its commitment to the United Nations Global Compact (UNGC) following the successful submission of our 2025 Communication on Progress (CoP).

As a participant in the world's largest corporate sustainability initiative, CSI continues to align its business operations with the Ten Principles of the UN Global Compact, covering human rights, labour, environmental responsibility and anti-corruption.

Embedding Responsible Business Practices

At CSI, sustainability extends beyond compliance. It influences how we operate across our global clinical trial supply chain, from responsible sourcing and ethical procurement to building trusted partnerships with manufacturers, suppliers and clients worldwide.

As a specialist in comparator sourcing and clinical trial supply, we recognise the importance of maintaining high standards of governance while supporting pharmaceutical, biotechnology and CRO clients across global studies.

Measuring Progress

Each year, participants in the UN Global Compact submit a Communication on Progress (CoP), outlining the actions they have taken to implement the Ten Principles and contribute to the UN Sustainable Development Goals.

The submission of our 2025 CoP demonstrates CSI's ongoing commitment to transparency, accountability and continuous improvement in our environmental, social and governance (ESG) performance.

Supporting a More Sustainable Future

Our participation in the UN Global Compact complements CSI's wider sustainability initiatives, including:

• EcoVadis Platinum rating, placing CSI among the top 1% of companies assessed globally

• Responsible sourcing and ethical supply chain management

• Strong corporate governance and compliance standards

• A continued focus on reducing environmental impact and supporting sustainable business practices

  
  

As the clinical research industry continues to evolve, CSI remains committed to helping clients deliver global clinical trials while operating responsibly and contributing to a more sustainable future.